Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 39:1353-1355
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lauer, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lauer, M. S.

CLINICAL STUDY: STRESS TESTING: EDITORIAL COMMENT

The "exercise" part of exercise echocardiography

Michael S. Lauer, MD, FACC*,*,*

* Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA

* Reprint requests and correspondence: Dr. Michael S. Lauer, Director of Clinical Research and Stress Laboratory, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Desk F25, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.
Lauerm{at}ccf.org


One of the most important tasks clinical cardiologists perform is assessment of risk (1). Recent work has focused on the ability of a number of measures to predict the likelihood of death or major cardiac event for the purpose of optimally targeting treatment at patients who are most likely to benefit (1). A number of technologies, new and old, have been subjected to the test of long-term follow-up, including exercise testing (2,3), nuclear imaging (4,5), stress echocardiography (6), carotid intimal medial thickness (7) and ankle brachial index (8).

With such a plethora of tests available, what tests should clinicians obtain, in what order and in which patients? Recent guidelines from the American College of Cardiology (ACC) and the American Heart Association (AHA) suggest that for patients thought to be at intermediate or high risk for coronary disease, as well as for patients with established disease, initial risk stratification test should involve some form of stress (9). If a patient can exercise, has an interpretable electrocardiogram and has not had prior revascularization, the test of choice is an exercise electrocardiogram without concurrent imaging. Patients deemed to be high risk should then be referred to coronary angiography, whereas low risk patients can be treated conservatively. Those patients whose predicted risk is still uncertain are appropriate candidates for imaging.

In this issue of the Journal, McCully et al. (10) present an interesting analysis that questions the approach recommended by the ACC/AHA guidelines (9). Previously, this group showed that patients with normal exercise echocardiograms are at very low risk for subsequent cardiac events (11). Now, they present the outcomes of 1,874 patients who underwent stress echocardiography with abnormalities either at rest or during exercise and who had a "good exercise capacity" defined simply as ≥7 METs in men and ≥5 METs in women (10). Those patients whose left ventricular end-systolic size failed to decrease during exercise or whose end-exercise left ventricular systolic function was severely impaired were at increased risk for cardiac death and other major cardiac events. In a multivariable analysis, the only independent predictors of outcome were diabetes mellitus, history of prior myocardial infarction and failure of left ventricular end-systolic size to decrease. The authors conclude that among their patients with a good exercise capacity but abnormal exercise echocardiograms, sophisticated analyses of exercise echocardiographic variables provide incremental information for identification of higher and lower risk groups.

An obvious implication of this study is that stress testing without concurrent echocardiography is not enough, as even among patients with a "good exercise capacity" the echocardiogram was of additional prognostic value. Can clinicians trust the exercise test alone to satisfactorily identify low risk patients? Or must concurrent imaging be performed straight away, even in the large number of patients who can exercise, have interpretable electrocardiograms and have no history of revascularization?

To answer these questions, we must first examine the stress test itself and its ability to stratify risk. Probably the most powerful stress test predictor of risk is exercise capacity (9). Because exercise capacity is closely related to age and gender, some researchers have defined impaired capacity according to prespecified age and gender categories (3,12). This is important as, for example, an exercise capacity of 7 METs has a very different prognostic meaning in a 40-year-old man than in a 70-year-old man. In the 40-year-old man, an exercise capacity that low predicts a substantially increased risk of death (3,12), whereas in the 70-year-old risk would not be increased.

Two other exercise predictors of outcome that provide important prognostic information over and above functional capacity and clinical variables are chronotropic response (13) and heart rate recovery (7,14–16). Chronotropic incompetence is present when the heart rate rise during exercise is attenuated; its presence is at least as prognostically ominous as a nuclear perfusion abnormality (13). However, its value is unclear in the setting of beta-blockade. Heart rate recovery is the fall in heart rate during the first few minutes after exercise and is thought to reflect vagal tone (17). An impaired heart rate recovery is predictive of death independent of exercise capacity (2,14), left ventricular function (15,16), nuclear perfusion abnormalities (2) and extent of angiographic coronary disease (15). Furthermore, heart rate recovery is predictive of death even when measured in patients taking beta-blockers (2,15).

The prognostic value of the exercise test is maximized when multiple exercise findings are considered. More than a decade ago, the Duke treadmill score was derived (18) and validated (19), incorporating exercise capacity with ST-segment changes and exercise-induced angina. Recent studies have confirmed the overriding importance of exercise capacity as a predictor of all-cause death and cardiac events (4,12,15,20), while ST-segment changes have not emerged as an independent predictor (14,15,20). When exercise test findings that truly have strong and independent prognostic value are considered together, the test is remarkably capable of identifying low and high risk patients (4,15,21,22).

Even if combining different exercise test findings does improve the ability of the test to stratify risk, we are still left with the question as to whether or not high risk patients might be missed if we were to rely on the exercise test alone. Two recent studies shed light on this issue. Shaw et al. (22) followed 3,620 medically treated patients who underwent exercise nuclear studies. A low risk Duke treadmill score was found in 921 patients (25%). Cardiac death rates among these patients with normal nuclear scans or with perfusion abnormalities in up to two vascular territories were only 0.3% and 0.4% per year. In the very few patients (n = 27) who had perfusion abnormalities in all three vascular territories, only one patient died. Diaz et al. (4) followed 7,163 patients for 6.7 years, during which time 855 died. Among the 4,514 patients who had not undergone prior revascularization, there were 2,018 (45%) who had at least average functional capacity for their age and gender and who had a normal 1-min heart rate recovery of >12 beats/min. All of these patients had all-cause death rates of <1% per year, even when the nuclear scan was substantially abnormal. There were 863 patients (19%) who had both impaired functional capacity and an abnormal heart rate recovery. In this group, the death rate exceeded 3% per year, even when the nuclear scan was completely normal. This left 1,633 patients (36%) who had either an impaired functional capacity or an abnormal heart rate recovery, but not both. It was among these patients that the nuclear scan was quite useful in separating the lower and higher risk subgroups.

Both of these large studies suggest that, irrespective of imaging data, the absolute risk of death is low when the exercise test, interpreted using some kind of composite measure, suggests low risk. A limitation of both reports (4,22), along with the current study of McCully et al. (10), is that they suffer from selection bias, in that the analyses were based on patients who for some reason were referred for stress testing combined with imaging. Patients in all three cohorts were higher risk with sizable subsets having established coronary disease or multiple risk factors. Thus, it is not all that surprising that the number of patients identified as low risk by the stress test alone was relatively low. In a recently reported cohort of 9,450 patients who were referred for stress testing alone without imaging, 86% of the patients could be identified as low risk with mortality rates of <1% per year when stress test prognostic interpretations incorporated the Duke treadmill score, chronotropic response and heart rate recovery (14,21).

Current ACC/AHA guidelines, backed up by the literature, support stress testing alone, especially when interpreted in an evidence-based sophisticated way, as a means to adequately identify low risk patients for whom further work-up is not needed. How then do we put the results of McCully et al. (10,11) into context?

The imaging technique they used was echocardiography, whereas most existing prognostic literature is based on nuclear imaging, which has been in common clinical use for a longer time. Comparative studies of the prognostic power of these two techniques are few, but suggest that they are probably similar (23).

The authors considered end points besides cardiac death, namely nonfatal myocardial infarction and late revascularization. These end points, which accounted for the vast majority of events, are clinically relevant, but likely suffer from ascertainment bias. Myocardial infarction was not adjudicated by a core laboratory, as is commonly done in clinical trials. Interpretations of electrocardiograms for diagnosis of myocardial infarction can be seriously biased when readers are aware of other clinical data (24). This is not just of academic interest, as it has been shown that electrocardiograms of patients with suspected acute coronary events are more predictive of subsequent events when evaluated by a core laboratory as opposed to local investigators (25). Similarly, it is quite plausible that performance of late revascularization is in some way influenced by clinicians’ knowledge of prior stress echocardiogram results. The most objective and probably least biased end point the investigators considered was cardiac death, which itself can suffer from significant ascertainment biases (26). Nevertheless, it is noteworthy that even in the cohort of patients of McCully et al. (10) with their definition of a good exercise capacity, failure of the left ventricular end-systolic size to decrease was associated with a cardiac death rate of only 1.1% per year.

The analyses by McCully et al. (10) provide evidence that careful, sophisticated interpretation of exercise echocardiograms can provide additional independent prognostic information over and above other clinical variables. Clinicians should realize, however, that sophisticated interpretation of the exercise stress test makes it an enormously powerful prognostic tool. Exercise capacity as a function of age and gender, chronotropic response and heart rate recovery should be routinely measured and considered. Among patients without a revascularization history, these measurements alone can identify a very large subset for whom conservative management and reassurance is appropriate. The real strength of imaging is found when it is performed in patients deemed to be at increased risk after clinical evaluation and after a carefully performed and interpreted exercise test.


    Footnotes
 
Dr. Lauer is supported by the National Heart, Lung and Blood Association (grant HL66004-01).

* Editorials published in the Journal of the American College of Cardiology reflect the views of the author and do not necessarily represent the views of JACC or the American College of Cardiology. Back


    References
 Top
 References
 
1. Califf RM, Armstrong PW, Carver JR, D’Agostino RB, Strauss WE. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol. 1996;27:1007–1019[CrossRef][Medline]

2. Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999;341:1351–1357[Abstract/Free Full Text]

3. Wei M, Kampert JB, Barlow CE, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA. 1999;282:1547–1553[Abstract/Free Full Text]

4. Diaz LA, Brunken RC, Blackstone EH, Snader CE, Lauer MS. Independent contribution of myocardial perfusion defects to exercise capacity and heart rate recovery for prediction of all-cause mortality in patients with known or suspected coronary heart disease. J Am Coll Cardiol. 2001;37:1558–1564[Abstract/Free Full Text]

5. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation. 1996;93:905–914[Abstract/Free Full Text]

6. Marwick TH, Mehta R, Arheart K, Lauer MS. Use of exercise echocardiography for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1997;30:83–90[Abstract]

7. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987–1993. Am J Epidemiol. 1997;146:483–494[Abstract/Free Full Text]

8. Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study: the Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 1999;19:538–545[Abstract/Free Full Text]

9. Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP–ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 1999;33:2092–2197[Free Full Text]

10. McCully RB, Roger VL, Mahoney DW, et al. Outcome after abnormal exercise echocardiography for patients with good exercise capacity: prognostic importance of the extent and severity of exercise-related left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1345–1352[Abstract/Free Full Text]

11. McCully RB, Roger VL, Mahoney DW, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol. 1998;31:144–149[Abstract/Free Full Text]

12. Snader CE, Marwick TH, Pashkow FJ, Harvey SA, Thomas JD, Lauer MS. Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol. 1997;30:641–648[Abstract]

13. Lauer MS, Francis GS, Okin PM, Pashkow FJ, Snader CE, Marwick TH. Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA. 1999;281:524–529[Abstract/Free Full Text]

14. Nishime EO, Cole CR, Blackstone EH, Pashkow FJ, Lauer MS. Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG. JAMA. 2000;284:1392–1398[Abstract/Free Full Text]

15. Shetler K, Marcus R, Froelicher VF, et al. Heart rate recovery: validation and methodologic issues. J Am Coll Cardiol. 2001;38:1980–1987[Abstract/Free Full Text]

16. Watanabe J, Thamilarasan M, Blackstone EH, Thomas JD, Lauer MS. Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography. Circulation. 2001;104:1911–1916[Abstract/Free Full Text]

17. Imai K, Sato H, Hori M, et al. Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. J Am Coll Cardiol. 1994;24:1529–1535[Abstract]

18. Mark DB, Hlatky MA, Harrell FE Jr, Lee KL, Califf RM, Pryor DB. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med. 1987;106:793–800[CrossRef][Medline]

19. Mark DB, Shaw L, Harrell FE Jr, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med. 1991;325:849–853[Abstract]

20. Goraya TY, Jacobsen SJ, Pellikka PA, et al. Prognostic value of treadmill exercise testing in elderly persons. Ann Intern Med. 2000;132:862–870[Abstract/Free Full Text]

21. Lauer MS. Exercise electrocardiogram testing and prognosis: novel markers and predictive instruments. Cardiol Clin. 2001;19:401–414[CrossRef][Medline]

22. Shaw LJ, Hachamovitch R, Peterson ED, et al. Using an outcomes-based approach to identify candidates for risk stratification after exercise treadmill testing. J Gen Intern Med. 1999;14:1–9[Medline]

23. Olmos LI, Dakik H, Gordon R, et al. Long-term prognostic value of exercise echocardiography compared with exercise 201T1, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation. 1998;98:2679–2686[Abstract/Free Full Text]

24. Gjorup T, Kelbaek H, Stenbygard L, Sorensen F, Godtfredsen J, Jensen AM. Effect of knowledge of serum enzyme concentrations on doctors’ interpretation of electrocardiographic manifestations in suspected myocardial infarction. Br Med J (Clin Res Ed). 1986;292:27

25. Holmvang L, Hasbak P, Clemmensen P, Wagner G, Grande P. Differences between local investigator and core laboratory interpretation of the admission electrocardiogram in patients with unstable angina pectoris or non–Q-wave myocardial infarction (a Thrombin Inhibition in Myocardial Ischemia [TRIM] substudy). Am J Cardiol. 1998;82:54–60[CrossRef][Medline]

26. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol. 1999;34:618–620[Free Full Text]




This article has been cited by other articles:


Home page
CirculationHome page
P. Kligfield and M. S. Lauer
Exercise Electrocardiogram Testing: Beyond the ST Segment
Circulation, November 7, 2006; 114(19): 2070 - 2082.
[Full Text] [PDF]


Home page
JWatch GeneralHome page
Patients with Good Exercise Capacity but Abnormal Exercise Echocardiography
Journal Watch (General), June 11, 2002; 2002(611): 2 - 2.
[Full Text]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lauer, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lauer, M. S.

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement